BioLife announces the launch of its first line of cannabinoid consumer products including six new tincture formulations.
BioLife Sciences Inc. (OTC:BLFE) is a commercialization accelerator of innovative and disruptive technologies for the healthcare, beauty and food & beverage industry sectors.
One of BioLife Science’s core building block strategies is to develop, partner and assist innovative companies with commercialization of leading-edge technologies.
BioLife announces the launch of its first line of cannabinoid consumer products including six new tincture formulations.
BioLife Sciences Inc. announced it has successfully received qualification of its Form 1-A with the SEC to raise up to $20,000,000
BioLife announced today that it has filed Form 1-A with the Securities and Exchange Commission (SEC) seeking to raise up to $20 million under a Tier 1…
BioLife Sciences is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors.
2831 Saint Rose Parkway Suite 200 Henderson, NV 89052 United States
Copyright © 2022 BioLife Sciences Inc. All Rights Reserved.
